Free fatty acids and cardiovascular outcome: a Chinese cohort study on stable coronary artery disease
- PMID: 28674554
- PMCID: PMC5485743
- DOI: 10.1186/s12986-017-0195-1
Free fatty acids and cardiovascular outcome: a Chinese cohort study on stable coronary artery disease
Abstract
Background: Studies have revealed that plasma level of free fatty acids (FFAs) is related to cardiovascular disease. However, the role of FFAs in clinical outcomes of stable coronary artery disease (SCAD) has been less evaluated. This study, therefore, was to investigate the predictive value of FFAs in Chinese cohort with angiography-proven SCAD.
Methods: A total of 1670 consecutive patients with angina-like chest pain who underwent coronary angiography were enrolled and followed up for an average time of 36.9 months. The baseline characteristics were collected. Clinical and biochemical parameters of patients with or without cardiovascular events (CVEs) including all-cause death, non-fatal myocardial infarction, ischemic stroke and coronary revascularization were compared. According to the quartiles of baseline FFAs, patients were divided into four groups. The relationship of FFAs level and CVEs was evaluated.
Results: During the follow-up period, 146 patients suffered from CVEs. Patients with CVEs had elevated plasma level of FFAs than patients without CVEs (P = 0.002). Using the Cox proportional hazards model, the unadjusted hazard ratio (HR) for CVEs in the fourth FFAs quartile was 2.09 (95% CI:1.32–3.33; P = 0.002) and was 1.80 (95% CI: 1.11–2.94; P = 0.018) after adjustment for traditional cardiovascular risk factors when compared with that in the first FFAs quartile.
Conclusions: The present study on Chinese cohort with angiography-proven SCAD suggested that increased plasma level of FFAs was an independent risk factor of CVEs.
Keywords: Cardiovascular events; Free fatty acids; Stable coronary artery disease.
Conflict of interest statement
Ethics approval and consent to participate
This protocol of the present study was complied with the Declaration of Helsinki, and was approved by the hospital ethics review board (Fu Wai Hospital and the National Center for Cardiovascular Diseases, Beijing, China). The informed consent was obtained from all the enrolled subjects.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Figures
Similar articles
-
Effects of glucose-insulin-potassium on myocardial substrate availability and utilization in stable coronary artery disease. Studies on myocardial carbohydrate, lipid and oxygen arterial-coronary sinus differences in patients with coronary artery disease.Am J Cardiol. 1975 Dec;36(7):929-37. doi: 10.1016/0002-9149(75)90085-5. Am J Cardiol. 1975. PMID: 1199950
-
Free fatty acids are independently associated with all-cause and cardiovascular mortality in subjects with coronary artery disease.J Clin Endocrinol Metab. 2006 Jul;91(7):2542-7. doi: 10.1210/jc.2006-0195. Epub 2006 Apr 4. J Clin Endocrinol Metab. 2006. PMID: 16595593
-
Age-Biomarkers-Clinical Risk Factors for Prediction of Cardiovascular Events in Patients With Coronary Artery Disease.Arterioscler Thromb Vasc Biol. 2018 Oct;38(10):2519-2527. doi: 10.1161/ATVBAHA.118.311726. Arterioscler Thromb Vasc Biol. 2018. PMID: 30354221
-
Secondary prevention of coronary artery disease with omega-3 fatty acids.Am J Cardiol. 2006 Aug 21;98(4A):61i-70i. doi: 10.1016/j.amjcard.2005.12.028. Epub 2006 May 30. Am J Cardiol. 2006. PMID: 16919518 Review.
-
Colchicine in Stable Coronary Artery Disease.Clin Ther. 2019 Jan;41(1):30-40. doi: 10.1016/j.clinthera.2018.09.011. Epub 2018 Nov 2. Clin Ther. 2019. PMID: 30396516 Review.
Cited by
-
The Role of Insulin Resistance in the Development of Complications after Coronary Artery Bypass Grafting in Patients with Coronary Artery Disease.Biomedicines. 2023 Nov 5;11(11):2977. doi: 10.3390/biomedicines11112977. Biomedicines. 2023. PMID: 38001977 Free PMC article.
-
Serum free fatty acids are associated with severe coronary artery calcification, especially in diabetes: a retrospective study.BMC Cardiovasc Disord. 2021 Jul 15;21(1):343. doi: 10.1186/s12872-021-02152-w. BMC Cardiovasc Disord. 2021. PMID: 34266394 Free PMC article.
-
Association of plasma free fatty acids levels with the presence and severity of coronary and carotid atherosclerotic plaque in patients with type 2 diabetes mellitus.BMC Endocr Disord. 2020 Oct 21;20(1):156. doi: 10.1186/s12902-020-00636-y. BMC Endocr Disord. 2020. PMID: 33087077 Free PMC article.
-
Free fatty acids, cardiovascular disease, and mortality in the Multi-Ethnic Study of Atherosclerosis.J Clin Lipidol. 2020 Jul-Aug;14(4):531-541. doi: 10.1016/j.jacl.2020.06.005. Epub 2020 Jun 10. J Clin Lipidol. 2020. PMID: 32651087 Free PMC article.
-
Microbe-Derived Butyrate and Its Receptor, Free Fatty Acid Receptor 3, But Not Free Fatty Acid Receptor 2, Mitigate Neointimal Hyperplasia Susceptibility After Arterial Injury.J Am Heart Assoc. 2020 Jul 7;9(13):e016235. doi: 10.1161/JAHA.120.016235. Epub 2020 Jun 25. J Am Heart Assoc. 2020. PMID: 32580613 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources